药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Paricalcitol
Practolol
Aminophenazone may decrease the antihypertensive activities of Practolol.
Paricalcitol
Bevantolol
Aminophenazone may decrease the antihypertensive activities of Bevantolol.
Paricalcitol
Pindolol
Aminophenazone may decrease the antihypertensive activities of Pindolol.
Paricalcitol
Cilazaprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aminophenazone is combined with Cilazaprilat.
Paricalcitol
Quinoline Yellow WS
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aminophenazone is combined with Quinoline Yellow WS.
Paricalcitol
Quinaprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aminophenazone is combined with Quinaprilat.
Paricalcitol
Perindoprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aminophenazone is combined with Perindoprilat.
Paricalcitol
Moexiprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aminophenazone is combined with Moexiprilat.
Paricalcitol
Trandolaprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aminophenazone is combined with Trandolaprilat.
Paricalcitol
Ramiprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aminophenazone is combined with Ramiprilat.
Paricalcitol
Fosinoprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aminophenazone is combined with Fosinoprilat.
Paricalcitol
Benazeprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aminophenazone is combined with Benazeprilat.
Paricalcitol
Delapril
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aminophenazone is combined with Delapril.
Paricalcitol
Zofenopril
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aminophenazone is combined with Zofenopril.
Paricalcitol
Imidapril
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aminophenazone is combined with Imidapril.
Paricalcitol
Enalaprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aminophenazone is combined with Enalaprilat.
Paricalcitol
Temocapril
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aminophenazone is combined with Temocapril.
Paricalcitol
Rescinnamine
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aminophenazone is combined with Rescinnamine.
Paricalcitol
Candesartan
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Aminophenazone.
Paricalcitol
Fimasartan
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Aminophenazone.